Dergiler / Turkish Journal of Medical Sciences / 2011 / Cilt: 41 - Sayı: 1

Efficacy of hyaluronic acid - carboxymethyl cellulose membrane (Seprafilm®) and polylactic acid barrier film (Surgiwrap™) for the prevention of adhesions after thyroid surgery: an experimental model

Sayfa
73–79
Yayın Tarihi
2011-01-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Similar studies are warranted to determine the clinical application of barrier agents in thyroid surgery.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Adhesions occurring after initial surgery increase complications in secondary thyroid operations.
📊
Temel Bulgular & Veri:Therefore use of anti-adhesive barriers may reduce complication rates of secondary thyroid operations.
💡
Sonuç & Katkı:Similar studies are warranted to determine the clinical application of barrier agents in thyroid surgery.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Key words: Anti-adhesive barriers · thyroidectomy · adhesion

Özet

Adhesions occurring after initial surgery increase complications in secondary thyroid operations. Therefore use of anti-adhesive barriers may reduce complication rates of secondary thyroid operations. In this study, we investigated the efficacy of hyaluronic acid-carboxymethyl cellulose membrane (HA-CMC, Seprafilm®) and polylactic acid barrier film (PLA, Surgiwrap™) in reducing adhesions after thyroid surgery. Materials and methods: A randomized-controlled experimental animal model was utilized. Forty-eight male Wistar Albino rats were randomly divided into 3 equal groups, forming study and control groups. Thyroid surgery was performed in all subjects. HA-CMC and PLA were applied between the thyroid zone and strap muscles after thyroid surgery in the HA-CMC and PLA study groups, respectively. Eight animals in each group were sacrificed and re-operated on day 7 and the rest on day 28. Two surgeons independently scored adhesion formation during the re-operation. Subsequently, thyroid and adjacent tissues were excised for histopathologic examination. Results: Surgical adhesion scores were significantly reduced in HA-CMC group compared to the control group both on day 7 and 28 re-operations (P = 0.005 and P = 0.001, respectively); however, no significant difference was observed between control and PLA groups. Histopathologically, on day 7 re-operations, cellular markers of adhesion were more prominent in both HA-CMC and PLA groups compared to the control group; however, on day 28 re-operations, adhesion markers were similar in HA-CMC and control subjects, whereas PLA subjects still had marked adhesion. Conclusion: Use of HA-CMC after primary thyroidectomy may reduce adhesion formation, and thereby the complication rate in secondary surgery. Similar studies are warranted to determine the clinical application of barrier agents in thyroid surgery.

Abstract

Adhesions occurring after initial surgery increase complications in secondary thyroid operations. Therefore use of anti-adhesive barriers may reduce complication rates of secondary thyroid operations. In this study, we investigated the efficacy of hyaluronic acid-carboxymethyl cellulose membrane (HA-CMC, Seprafilm®) and polylactic acid barrier film (PLA, Surgiwrap™) in reducing adhesions after thyroid surgery. Materials and methods: A randomized-controlled experimental animal model was utilized. Forty-eight male Wistar Albino rats were randomly divided into 3 equal groups, forming study and control groups. Thyroid surgery was performed in all subjects. HA-CMC and PLA were applied between the thyroid zone and strap muscles after thyroid surgery in the HA-CMC and PLA study groups, respectively. Eight animals in each group were sacrificed and re-operated on day 7 and the rest on day 28. Two surgeons independently scored adhesion formation during the re-operation. Subsequently, thyroid and adjacent tissues were excised for histopathologic examination. Results: Surgical adhesion scores were significantly reduced in HA-CMC group compared to the control group both on day 7 and 28 re-operations (P = 0.005 and P = 0.001, respectively); however, no significant difference was observed between control and PLA groups. Histopathologically, on day 7 re-operations, cellular markers of adhesion were more prominent in both HA-CMC and PLA groups compared to the control group; however, on day 28 re-operations, adhesion markers were similar in HA-CMC and control subjects, whereas PLA subjects still had marked adhesion. Conclusion: Use of HA-CMC after primary thyroidectomy may reduce adhesion formation, and thereby the complication rate in secondary surgery. Similar studies are warranted to determine the clinical application of barrier agents in thyroid surgery.

🔖

Bu Makaleye Atıf Yap

ÇİPE, G., KÖKSAL, H. M., YILDIRIM, S., CELAYİR, M. F., BAYKAN, A. (2011). Efficacy of hyaluronic acid - carboxymethyl cellulose membrane (Seprafilm®) and polylactic acid barrier film (Surgiwrap™) for the prevention of adhesions after thyroid surgery: an experimental model. Turkish Journal of Medical Sciences, Cilt: 41 - Sayı: 1, 73–79. https://ajindex.com/articles/723599

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Auguste LJ, Attie NJ. Completion thyroidectomy for initially misdiagnosed thyroid cancer. Otolaryngol Clin N Am 1990; 23: 429-439.
  2. Chao TC, Jeng LB, Lin JD, Chen MF. Completion thyroidectomy for differentiated thyroid carcinoma. Otolaryngol Head Neck Surg 1998; 118: 896-899. 3. Eroğlu A, Berberoğlu U, Buruk F, Yıldırım E. Completion thyroidectomy for differantiated thyroid carcinoma. J Surg Oncol 1995; 59: 261-266. Pezzulo L,Delrio P, Losito NS, Caraco C, Mozzillo N. Postoperative complications after completion thyroidectomy for differentiated thyroid cancer. Eur J Surg Oncol 1997; 23: 215- 218. 5. Dralle H, Sekulla C, Lorenz K, Brauckhoff M, Machens A; German IONM Study Group. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery. World J Surg 2008; 32: 1358-1366. 6. Sitreq-Serra A, Saucho JJ. Surgical management of recurrent and intrathoracic goiters. In Clark OH, Duk AY, editors, Textbook of Endocrine Surgery, WB. Saunders Comp., Philadephia, 1997; 262-274.
  3. Muller PE, Jakoby R, Heinert G, Spelsberg F. Surgery for recurrent goitre: its complications and their risk factors. Eur J Surg 2001; 167: 816-821. 8. Pasieka JL, Thompson NW, McLeod MK, Burney RE, Macha M. The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy. World J Surg 1992; 16: 711- 716. 9. De Jong SA, Demeter JG, Lawrence AM, Paloyan E. Necessity and safety of completion thyroidectomy for differentiated thyroid carcinoma. Surgery 1992; 112: 734-739.
  4. DeCherney AH, DiZerega GS. Clinical problem of intraperitoneal postsurgical adhesion formation following general surgery and the use of adhesion prevention barriers. Surg Clin North Am 1997; 77: 671-688. Diamond MP. Reduction of adhesions after uterine myomectomy by Seprafilm membrane: a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group. Fertil Steril 1996; 66: 904-910. Diamond MP. Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertil Steril 1998; 69: 1067-1074.
  5. Zeng Q, Yu Z., You J, Zhang Q. Efficiency and safety of seprafilm for preventing postoperative abdominal adhesions: systemic review and metaanalysis. World J Surg 2007; 31: 2125-2131.
  6. Yigit O, Uslu Coskun B., Coskun H, Yilmaz B, Alkan S, Cinar U et al. Efficacy of antiadhesive barriers in secondary thyroidectomy: an experimen